FAAH inhibition ameliorates breast cancer in a murine model

Inhibition of Fatty Acid Amide Hydrolase (FAAH) Regulates NF-kb Pathways Reducing Bleomycin-Induced Chronic Lung Inflammation and Pulmonary Fibrosis

(2023) Tiziana Genovese et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cancer statistics, 2022

(2022) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Inactivation of fatty acid amide hydrolase protects against ischemic reperfusion injury-induced renal fibrogenesis

(2022) Chaoling Chen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Current and future burden of breast cancer: Global statistics for 2020 and 2040

(2022) Melina Arnold et al.   BREAST

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review

(2021) Sergiusz Łukasiewicz et al.   Cancers

Therapeutic targeting of HER2–CB2R heteromers in HER2-positive breast cancer

(2019) Sandra Blasco-Benito et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Breast Cancer Treatment

(2019) Adrienne G. Waks et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Modulation of the Endocannabinoid System as a Potential Anticancer Strategy

(2019) Robert Ramer et al.   Frontiers in Pharmacology

Breast cancer

(2019) Nadia Harbeck et al.   Nature Reviews Disease Primers

Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System

(2018) et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The global burden of women’s cancers: a grand challenge in global health

(2017) Ophira Ginsburg et al.   LANCET

Fatty Acid Amide Hydrolase Regulates Peripheral B Cell Receptor Revision, Polyreactivity, and B1 Cells in Lupus

(2016) Simanta Pathak et al.   JOURNAL OF IMMUNOLOGY

Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells

(2016) A. Ortega et al.   LIFE SCIENCES

FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway

(2015) Janani Ravi et al.   Oncotarget

HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer

(2014) R Schulz et al.   Cell Death & Disease

Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells

(2012) Chiara Laezza et al.   EUROPEAN JOURNAL OF CANCER

Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor

(2011) Li Huang et al.   LABORATORY INVESTIGATION

Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase

(2010) L Thors et al.   BRITISH JOURNAL OF PHARMACOLOGY

Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders

(2009) Kay Ahn et al.   Expert Opinion on Drug Discovery

A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis

(2009) Rosanna Cozzolino et al.   INVESTIGATIONAL NEW DRUGS

Cancer survival in Africa, Asia, and Central America: a population-based study

(2009) Rengaswamy Sankaranarayanan et al.   LANCET ONCOLOGY

The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway

(2008) Sharon DeMorrow et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

“Westernizing” Women's Risks? Breast Cancer in Lower-Income Countries

(2008) Peggy Porter   NEW ENGLAND JOURNAL OF MEDICINE